Detailed explanation of the latest price and purchasing channels of Lenvatinib

Lenvatinib, also known as Lenvatinib, is a multi-target tyrosine kinase inhibitor commonly used to treat a variety of solid tumors such as hepatocellular carcinoma, thyroid cancer, renal cell carcinoma, and endometrial cancer. As the therapeutic effect is widely recognized, lenvatinib has been officially launched in mainland China and has been included in the national medical insurance directory, which has greatly improved patients' medication accessibility and affordability, and has become one of the important choices for clinical treatment.

In the domestic market, the common specifications of lenvatinib are 4mg*30 capsules, and the price per box is about 3000 yuan. Due to the inclusion of medical insurance, eligible patients can fill prescriptions in the hospital and have their medicines reimbursed proportionally. After reimbursement, the actual out-of-pocket amount will be significantly reduced. However, medical insurance policies vary slightly from place to place. For specific reimbursement ratios, deductibles and restrictions, patients are advised to consult the local hospital pharmacy or medical insurance office for the latest information.

In addition to domestic channels, some patients will also pay attention to overseas purchasing channels. In foreign markets, the price of lenvatinib’s original drug is generally lower than the domestic price. For example, the price of original drugs sold in official pharmacies in some countries, such as India or Bangladesh, is about 2000 RMB. Although these drugs are original research versions, due to different regional pricing strategies, the overall cost-effectiveness is high, and they are favored by some patients, especially those who cannot be reimbursed by medical insurance.

In addition, there are also imitation versions produced in Laos, Bangladesh and other places on the market, and the prices are even lower, ranging from 400 yuan to 900 yuan per box. These generic drugs are basically the same as the original drugs in terms of ingredients and dosage forms, and can meet most clinical drug needs. However, when choosing generic drugs, patients are advised to obtain them through formal channels to ensure the safety and efficacy of the drugs. At the same time, they should be used under the guidance of professional doctors to avoid self-judgment and abuse.

Reference materials:https://www.drugs.com/